Gene · 407031
Papers2,938
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,938
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs: Midfielders of Cardiac Health, Disease and Treatment. | Int J Mol Sci | 2023 | 38003397 | PubTator, text mining | PubMed |
| miRNA Expression Patterns in Early- and Late-Stage Prostate Cancer Patients: High-Throughput Analysis. | Biomedicines | 2023 | 38002073 | PubTator, text mining | PubMed |
| Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis. | Cancers (Basel) | 2023 | 38001599 | PubTator, text mining | PubMed |
| In silico analysis of prognostic and diagnostic significance of target genes from prostate cancer cell lines derived exomicroRNAs. | Cancer Cell Int | 2023 | 37978493 | PubTator, text mining | PubMed |
| Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer. | Biomark Res | 2023 | 37968730 | PubTator, text mining | PubMed |
| Stem cells and exosomes: as biological agents in the diagnosis and treatment of polycystic ovary syndrome (PCOS). | Front Endocrinol (Lausanne) | 2023 | 37964963 | PubTator, text mining | PubMed |
| Synergy of the microRNA Ratio as a Promising Diagnosis Biomarker for Mucinous Borderline and Malignant Ovarian Tumors. | Int J Mol Sci | 2023 | 37958997 | PubTator, text mining | PubMed |
| The Role of Longevity Assurance Homolog 2/Ceramide Synthase 2 in Bladder Cancer. | Int J Mol Sci | 2023 | 37958652 | PubTator, text mining | PubMed |
| Atherosclerosis and Its Related Laboratory Biomarkers. | Int J Mol Sci | 2023 | 37958528 | PubTator, text mining | PubMed |
| MiRNAs and Their Role in Venous Thromboembolic Complications. | Diagnostics (Basel) | 2023 | 37958279 | PubTator, text mining | PubMed |
| Development of a potency assay for CD34+ cell-based therapy. | Sci Rep | 2023 | 37952030 | PubTator, text mining | PubMed |
| Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP. | BMJ Open | 2023 | 37940151 | PubTator, text mining | PubMed |
| Significance of LINC02082 and LOC105369812 in differentiating papillary thyroid cancer from benign nodules. | Medicine (Baltimore) | 2023 | 37932992 | PubTator, text mining | PubMed |
| Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation. | Front Immunol | 2023 | 37915578 | PubTator, text mining | PubMed |
| Differential expression of plasma‑derived exosomal miRNAs in polycystic ovary syndrome as a circulating biomarker. | Biomed Rep | 2023 | 37901874 | PubTator, text mining | PubMed |
| Early to sustained impacts of lethal radiation on circulating miRNAs in a minipig model. | Sci Rep | 2023 | 37898651 | PubTator, text mining | PubMed |
| Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression. | Genes (Basel) | 2023 | 37895302 | PubTator, text mining | PubMed |
| Circulating microRNA Panels for Detection of Liver Cancers and Liver-Metastasizing Primary Cancers. | Int J Mol Sci | 2023 | 37895131 | PubTator, text mining | PubMed |
| MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate. | Biomedicines | 2023 | 37893133 | PubTator, text mining | PubMed |
| In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer. | Biomedicines | 2023 | 37893081 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407031/papers?page=7